Skip to content

Study with Copeptin as predictor of outcome in patients with a subarachnoid haemorrhage from a ruptured cerebral aneurysm.

Tilburg Copeptin in aSAH patients Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22580
Enrollment
103
Registered
2013-08-15
Start date
2013-10-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subarachnoid haemorrhage from a ruptured cerebral aneurysm, aSAH, delayed cerebral ischaemia, DCI.

Interventions

For copeptin levels in the aSAH group, blood will be drawn in an extra serum tube of 5 ml on the first 24 hours of admission at the ICU.

Sponsors

Intensive Care St. Elisabeth Hospital Tilburg Hilvarenbeekseweg 60 5022 GC Tilburg +31(0)135393808
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Admission to the intensive care of the St. Elisabeth Hospital Tilburg. Age 18 year or over. Start clinical symptoms of SAH within 24hr at admission. Informed consent to participate in the trial. Aneurysm confirmed by computerized tomography angiography (CT-A) with or without digital substraction angiography (DSA). Blood drawn after obtaining informed consent on the first 24 hours of admission at de ICU.

Exclusion criteria

Exclusion criteria: Less than 18 years of age. Severe language barrier, unable to read the informed consent. SAH due to non- aneurysmal causes. Recent ischemic or hemorrhagic stroke (< 30 days). Recent intracerebral hemorrhage without subarachnoid blood (< 30 days). Existing recent head trauma (< 30 days). Recent acute myocardial infarction (AMI)(< 30 days). Chronic heart failure. Recent acute exacerbation of COPD (AECOPD) (< 30 days). Recent sepsis/septic shock (< 30 days). Recent acute pancreatiits (< 30 days). Liver cirrhosis.

Design outcomes

Primary

MeasureTime frame
The primary objective is to investigate the ability of copeptin to predict poor one-year functional outcome, GOS 1-3, in patients with aneurysmal SAH in the Dutch population.

Secondary

MeasureTime frame
•Development of DCI •Case fatality 30 days after admission •One year mortality •Functional outcome 12 months after aSAH, assessed by both the Glasgow Outcome Scale and the modified Ranking Scale.

Contacts

Public ContactJ.A.H. Oers, van

internist-intensivist Intensive Care St. Elisabeth Hospital Tilburg Hilvarenbeekseweg 60

j.v.oers@elisabeth.nl+31(0)135393808

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)